Collegium to Participate in H.C. Wainwright Global Investment Conference

STOUGHTON, Mass., May 17, 2022 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a leading, diversified specialty pharmaceutical company, today announced that management will present at the H.C. Wainwright Global Investment Conference being held at the Fontainebleau Miami Beach Hotel from May 23-26, 2022.

Details of the event are as follows:
Presentation Date and Time: Tuesday, May 24, 2022, at 3:30 pm ET

About Collegium Pharmaceutical, Inc.
Collegium is a diversified, specialty pharmaceutical company committed to improving the lives of people living with serious medical conditions. Collegium’s headquarters are located in Stoughton, Massachusetts. For more information, please visit the Company’s website at www.collegiumpharma.com.

Contact:
Alex Dasalla
Head of Investor Relations
[email protected]

You May Also Be Interested In

• KAIYI X7 Hybrid: Efficient Power for Every Journey
• New lending volumes increased, and capital adequacy continued to strengthen – comparable profit before taxes for January–June amounted to EUR 23.6 million
• AB KN Energies (KNE) will hold an Investor Conference Webinar to introduce unaudited financial results for the six months of 2026